文献速递关节外科

钙卫蛋白侧流试验:在排除假体周围关节感染时各标准间结果一致

Calprotectin Lateral Flow Test: Consistent Across Criteria for Ruling Out Periprosthetic Joint Infection.
PubMed 文献 · J Arthroplasty · 2022-02-03

研究前瞻性收集123例翻修全膝关节置换术患者术中滑液样本,用钙卫蛋白侧流即时检测诊断假体周围关节感染,以2013 MSIS、2018 ICM和2019 EBJIS三套标准为参考,三套标准间一致率91.8%,检测在各标准下敏感性和特异性均优良,以2018 ICM标准下表现最佳。

要点

  • 钙卫蛋白侧流即时检测在三种假体周围关节感染定义下均显示优良敏感性和特异性。
  • 2018 ICM标准下检测AUC为0.984,为三种标准中最高。
  • 2019 EBJIS标准下特异性为100.0%,敏感性为93.2%。

核心结论

  • 钙卫蛋白侧流即时检测在目前可用的假体周围关节感染定义下具有优良的敏感性和特异性,以2018 ICM标准应用时表现最佳。

研究设计与样本

  • 前瞻性收集2018年10月至2020年1月间123份翻修全膝关节置换术患者术中滑液样本,用钙卫蛋白侧流即时检测 assay 检测。
  • 数据由2名对钙卫蛋白检测结果设盲的独立评估者审阅和裁定。
  • 研究证据等级为诊断I级。

主要发现

  • 三种标准集间一致率为91.8%。
  • 以2013 MSIS标准为参考,检测敏感性98.1%、特异性95.7%、PPV 94.5%、NPV 98.5%、AUC 0.969。
  • 以2018 ICM标准为参考,检测敏感性98.2%、特异性98.5%、PPV 98.2%、NPV 98.5%、AUC 0.984。
  • 以2019拟议EBJIS标准为参考,检测敏感性93.2%、特异性100.0%、PPV 100.0%、NPV 94.2%、AUC 0.966。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are multiple sets of criteria used to define periprosthetic joint infection. The objective of this study is to compare the diagnostic accuracy of the calprotectin lateral flow point-of-care (POC) test in total knee arthroplasty (TKA) patients to diagnose infection using 3 different sets of criteria: (1) 2013 Musculoskeletal Infection Society, (2) 2018 Intentional Consensus Meeting (ICM), and (3) the 2019 proposed European Bone and Joint Infection Society criteria as reference standards. METHODS: From October 2018 to January 2020, 123 intraoperative synovial fluid samples were prospectively collected from revision total knee arthroplasty patients and tested using a calprotectin lateral flow POC assay. Data were reviewed and adjudicated by 2 independent reviewers blinded to calprotectin test results. RESULTS: The 3 criteria sets had 91.8% agreement. Using 2013 Musculoskeletal Infection Society criteria, the POC test demonstrated a sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) of 98.1%, 95.7%, 94.5%, 98.5%, and 0.969, respectively. Using the 2018 ICM, the POC test demonstrated a sensitivity, specificity, PPV, NPV, and AUC of 98.2%, 98.5%, 98.2%, 98.5%, and 0.984, respectively. Using the 2019 proposed European Bone and Joint Infection Society criteria, the POC test demonstrated a sensitivity, specificity, PPV, NPV, and AUC of 93.2%, 100.0%, 100.0%, 94.2%, and 0.966, respectively. CONCLUSION: The calprotectin lateral flow POC test had excellent sensitivity and specificity across current available periprosthetic joint infection definitions, with the best performance observed when applying 2018 ICM criteria. LEVEL OF EVIDENCE: Diagnostic I.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Warren JA, Klika AK, Bowers K, et al. Calprotectin Lateral Flow Test: Consistent Across Criteria for Ruling Out Periprosthetic Joint Infection. J Arthroplasty. 2022. PMID: 35122946. doi:10.1016/j.arth.2022.01.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。